--The U.S. Supreme Court has ordered a lower court to reconsider a decision to allow certain lawsuits against pharmaceutical company Merck & Co. (MRK) to move forward, Reuters reports Monday.

--The 3rd U.S. Circuit Court of Appeals had earlier decided to allow lawsuits, which alleged Merck didn't properly warn users about possible side effects from its drug Fosamax, the report said.

--Merck in 2008 gave information to the U.S. Food and Drug Administration that suggested Fosamax might be linked to certain types of fractures, but the agency at the time decided against letting the company add a warning to the drug's label, the report said.

--Two years later, the FDA ordered changes made to the drug's label to include a warning, the report said.

Full story: https://www.reuters.com/article/us-usa-court-merck-co/u-s-supreme-court-tosses-ruling-against-merck-on-fosamax-osteoporosis-drug-idUSKCN1SQ1K3

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

May 20, 2019 14:05 ET (18:05 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Merck Charts.